Literature DB >> 34742947

Sex differences in inflammatory cytokine levels following synthetic cathinone self-administration in rats.

Julie A Marusich1, Elaine A Gay2, Delisha A Stewart3, Bruce E Blough2.   

Abstract

Synthetic cathinones are used as stimulants of abuse. Many abused drugs, including stimulants, activate nuclear factor-κB (NF-κB) transcription leading to increases in NF-κB-regulated pro-inflammatory cytokines, and the level of inflammation appears to correlate with length of abuse. The purpose of this study was to measure the profile of IL-1α, IL-1β, IL-6, CCL2 and TNF-α in brain and plasma to examine if drug exposure alters inflammatory markers. Male and female Sprague-Dawley rats were trained to self-administer α-pyrrolidinopentiophenone (α-PVP) (0.1 mg/kg/infusion), 4-methylmethcathinone (4MMC) (0.5 mg/kg/infusion), or saline through autoshaping, and then self-administered for 21 days during 1 h (short access; ShA) or 6 h (long access; LgA) sessions. Separate rats were assigned to a naïve control group. Cytokine levels were examined in amygdala, hippocampus, hypothalamus, prefrontal cortex, striatum, thalamus, and plasma. Rats acquired synthetic cathinone self-administration, and there were no sex differences in drug intake. Synthetic cathinone self-administration produced sex differences in IL-1α, IL-1β, IL-6, CCL2 and TNF-α levels. There were widespread increases in inflammatory cytokines in the brains of male rats compared to females, particularly for 4MMC, whereas females were more likely to show increased inflammatory cytokines in plasma compared to saline groups than males. Furthermore, these sex differences in cytokine levels were more common after LgA access to synthetic cathinones than ShA. These results suggest that synthetic cathinone use likely produces sex-selective patterns of neuroinflammation during the transition from use to abuse. Consequently, treatment need may differ depending on the progression of synthetic cathinone abuse and based on sex.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cytokine; Mephedrone; Neuroimmune; Neuroinflammation; Self-administration; α-PVP

Mesh:

Substances:

Year:  2021        PMID: 34742947      PMCID: PMC8748414          DOI: 10.1016/j.neuro.2021.11.002

Source DB:  PubMed          Journal:  Neurotoxicology        ISSN: 0161-813X            Impact factor:   4.294


  43 in total

1.  Plasma profile of pro-inflammatory cytokines and chemokines in cocaine users under outpatient treatment: influence of cocaine symptom severity and psychiatric co-morbidity.

Authors:  Pedro Araos; María Pedraz; Antonia Serrano; Miguel Lucena; Vicente Barrios; Nuria García-Marchena; Rafael Campos-Cloute; Juan J Ruiz; Pablo Romero; Juan Suárez; Elena Baixeras; Rafael de la Torre; Jorge Montesinos; Consuelo Guerri; Marta Rodríguez-Arias; José Miñarro; Roser Martínez-Riera; Marta Torrens; Julie A Chowen; Jesús Argente; Barbara J Mason; Francisco J Pavón; Fernando Rodríguez de Fonseca
Journal:  Addict Biol       Date:  2014-05-22       Impact factor: 4.280

Review 2.  Biological basis of sex differences in drug abuse: preclinical and clinical studies.

Authors:  Wendy J Lynch; Megan E Roth; Marilyn E Carroll
Journal:  Psychopharmacology (Berl)       Date:  2002-09-05       Impact factor: 4.530

3.  Sex differences in α-pyrrolidinopentiophenone (α-PVP)-induced taste avoidance, place preference, hyperthermia and locomotor activity in rats.

Authors:  Katharine H Nelson; Hayley N Manke; Aikerim Imanalieva; Kenner C Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2019-08-21       Impact factor: 3.533

4.  Cocaine dependence and acute cocaine induce decreases of monocyte proinflammatory cytokine expression across the diurnal period: autonomic mechanisms.

Authors:  Michael R Irwin; Luis Olmos; Minge Wang; Edwin M Valladares; Sarosh J Motivala; Tim Fong; Tom Newton; Anthony Butch; Richard Olmstead; Steve W Cole
Journal:  J Pharmacol Exp Ther       Date:  2006-10-26       Impact factor: 4.030

5.  3,4-Methylenedioxypyrovalerone prevents while methylone enhances methamphetamine-induced damage to dopamine nerve endings: β-ketoamphetamine modulation of neurotoxicity by the dopamine transporter.

Authors:  John H Anneken; Mariana Angoa-Pérez; Donald M Kuhn
Journal:  J Neurochem       Date:  2015-03-02       Impact factor: 5.372

6.  Pharmacological effects of methamphetamine and alpha-PVP vapor and injection.

Authors:  Julie A Marusich; Timothy W Lefever; Bruce E Blough; Brian F Thomas; Jenny L Wiley
Journal:  Neurotoxicology       Date:  2016-05-26       Impact factor: 4.294

Review 7.  Induction of innate immune genes in brain create the neurobiology of addiction.

Authors:  F T Crews; Jian Zou; Liya Qin
Journal:  Brain Behav Immun       Date:  2011-03-21       Impact factor: 7.217

8.  An assessment of MDPV-induced place preference in adult Sprague-Dawley rats.

Authors:  Heather E King; Bradley Wetzell; Kenner C Rice; Anthony L Riley
Journal:  Drug Alcohol Depend       Date:  2014-11-12       Impact factor: 4.492

9.  Escalation of intravenous self-administration of methylone and mephedrone under extended access conditions.

Authors:  Jacques D Nguyen; Yanabel Grant; Kevin M Creehan; Sophia A Vandewater; Michael A Taffe
Journal:  Addict Biol       Date:  2016-04-05       Impact factor: 4.280

10.  Granulocyte-colony stimulating factor controls neural and behavioral plasticity in response to cocaine.

Authors:  Erin S Calipari; Arthur Godino; Emily G Peck; Marine Salery; Nicholas L Mervosh; Joseph A Landry; Scott J Russo; Yasmin L Hurd; Eric J Nestler; Drew D Kiraly
Journal:  Nat Commun       Date:  2018-01-16       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.